These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26283963)
1. Targeting brain tumor cAMP: the case for sex-specific therapeutics. Warrington NM; Sun T; Rubin JB Front Pharmacol; 2015; 6():153. PubMed ID: 26283963 [TBL] [Abstract][Full Text] [Related]
2. The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients. Warrington NM; Sun T; Luo J; McKinstry RC; Parkin PC; Ganzhorn S; Spoljaric D; Albers AC; Merkelson A; Stewart DR; Stevenson DA; Viskochil D; Druley TE; Forys JT; Reilly KM; Fisher MJ; Tabori U; Allen JC; Schiffman JD; Gutmann DH; Rubin JB Cancer Res; 2015 Jan; 75(1):16-21. PubMed ID: 25381154 [TBL] [Abstract][Full Text] [Related]
3. Intersections at the crossroads: Neurofibromatosis type 1, cAMP, sex, and glioma risk. Rubin JB Mol Cell Oncol; 2016 May; 3(3):e1069917. PubMed ID: 27314079 [TBL] [Abstract][Full Text] [Related]
4. Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy. Guo R; Liu T; Shasaltaneh MD; Wang X; Imani S; Wen Q Front Oncol; 2022; 12():829212. PubMed ID: 35832555 [TBL] [Abstract][Full Text] [Related]
5. Increased Plasma Levels of Adenylate Cyclase 8 and cAMP Are Associated with Obesity and Type 2 Diabetes: Results from a Cross-Sectional Study. Abdel-Halim SM; Al Madhoun A; Nizam R; Melhem M; Cherian P; Al-Khairi I; Haddad D; Abu-Farha M; Abubaker J; Bitar MS; Al-Mulla F Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32847122 [TBL] [Abstract][Full Text] [Related]
8. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells. Law PY; Loh HH Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986 [TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1. Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698 [TBL] [Abstract][Full Text] [Related]
10. The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon. DeRubertis FR; Chayoth R; Field JB J Clin Invest; 1976 Mar; 57(3):641-9. PubMed ID: 175089 [TBL] [Abstract][Full Text] [Related]
11. Sex differences in SR Ca(2+) release in murine ventricular myocytes are regulated by the cAMP/PKA pathway. Parks RJ; Ray G; Bienvenu LA; Rose RA; Howlett SE J Mol Cell Cardiol; 2014 Oct; 75():162-73. PubMed ID: 25066697 [TBL] [Abstract][Full Text] [Related]
12. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708 [TBL] [Abstract][Full Text] [Related]
13. Biphasic effect of cAMP-elevating agents on ICAM-1 expression stimulated by retinoic acid and interferon gamma. Bouillon M; Fortier MA; Boulianne R; Audette M Int J Cancer; 1992 Jan; 50(2):281-8. PubMed ID: 1370436 [TBL] [Abstract][Full Text] [Related]
14. Identification of phosphodiesterase IV activity and its cyclic adenosine monophosphate-dependent up-regulation in a human keratinocyte cell line (HaCaT). Tenor H; Hatzelmann A; Wendel A; Schudt C J Invest Dermatol; 1995 Jul; 105(1):70-4. PubMed ID: 7615979 [TBL] [Abstract][Full Text] [Related]
15. Oviduct cells express the cyclic AMP-adenosine pathway. Cometti B; Dubey RK; Imthurn B; Jackson EK; Rosselli M Biol Reprod; 2003 Sep; 69(3):868-75. PubMed ID: 12724271 [TBL] [Abstract][Full Text] [Related]
16. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1. Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514 [TBL] [Abstract][Full Text] [Related]
17. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram. Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614 [TBL] [Abstract][Full Text] [Related]
18. Evidence that parathyroid hormone-mediated calcium transport in rat brain synaptosomes is independent of cyclic adenosine monophosphate. Fraser CL; Sarnacki P; Budayr A J Clin Invest; 1988 Apr; 81(4):982-8. PubMed ID: 2832450 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclic-3',5'-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production. Meng X; Ao L; Shames BD; Harken AH J Surg Res; 2001 Dec; 101(2):210-5. PubMed ID: 11735278 [TBL] [Abstract][Full Text] [Related]
20. Modulation of corticotropin-releasing hormone stimulated cyclic adenosine monophosphate production by brain cells. Kapcala LP; Aguilera G Brain Res; 1995 Apr; 678(1-2):207-12. PubMed ID: 7620889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]